App doesn’t work
Don’t bother with this app. It just stays on loading screen forever
CTC-AE+
The adverse event logger
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
CTC-AE+ is a browsable reference to the CTC-AE list of adverse event (AE) terms commonly encountered in oncology, plus a portable Adverse Event Logger to keep track of all adverse events during a clinical study.
The CTC-AE 4 and CTC-AE 5 have been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria). Each AE term is defined and accompanied by a grading scale that indicates the severity of the adverse event. All AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA).
Adverse events are common phenomena affecting patients being treated for cancer. With the availability of new agents and the multimodality interventions, it is critical to monitor systematically the AEs that are linked to oncology research.
CTCAE is fundamentally intended to be an agreed upon terminology for the designation, reporting, and grading of AEs that occur in oncology research.
########################
CTC-AE serves several purposes
########################
- To standardize AE reporting within the NCI oncology research community, across groups and modalities.
- To facilitate the evaluation of new cancer therapies, treatment modalities, and supportive measures.
- To aid in AE recognition and severity grading.
- To monitor safety data and for regulatory reporting.
- To define oncology research protocol parameters (e.g., eligibility criteria; dose-limiting toxicity; maximum tolerated dose; dose modification).
########################
KARNOFSKY and ECOG
########################
Additionally, CTC-AE+ now includes the two most common performance scores. As a reference and as a guided algorithm when necessary to add the event to the patient's record.
########################
ADVERSE EVENT LOGGER
########################
The Adverse Event Logger is a structured local database to help the investigator to keep track of all the adverse events related to the patients participating in a clinical trial.
It is possible to track multiple clinical studies, multiple patients per clinical trial and multiple events per patient. Events can be selected from the CTC-AE 4 and CTC-AE 5 databases, from Karnofsky and ECOG score tables or can be entered as customized events.
For convenience, all data can be exported as an excel CSV file to be imported into other analysis software.
########################
IMPORTANT NOTE
########################
This application is strictly EU GDPR compliant and no clinical study or patient information is saved outside the device or uploaded to any remote cloud resources.
Hide..
Show more..
The CTC-AE 4 and CTC-AE 5 have been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria). Each AE term is defined and accompanied by a grading scale that indicates the severity of the adverse event. All AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA).
Adverse events are common phenomena affecting patients being treated for cancer. With the availability of new agents and the multimodality interventions, it is critical to monitor systematically the AEs that are linked to oncology research.
CTCAE is fundamentally intended to be an agreed upon terminology for the designation, reporting, and grading of AEs that occur in oncology research.
########################
CTC-AE serves several purposes
########################
- To standardize AE reporting within the NCI oncology research community, across groups and modalities.
- To facilitate the evaluation of new cancer therapies, treatment modalities, and supportive measures.
- To aid in AE recognition and severity grading.
- To monitor safety data and for regulatory reporting.
- To define oncology research protocol parameters (e.g., eligibility criteria; dose-limiting toxicity; maximum tolerated dose; dose modification).
########################
KARNOFSKY and ECOG
########################
Additionally, CTC-AE+ now includes the two most common performance scores. As a reference and as a guided algorithm when necessary to add the event to the patient's record.
########################
ADVERSE EVENT LOGGER
########################
The Adverse Event Logger is a structured local database to help the investigator to keep track of all the adverse events related to the patients participating in a clinical trial.
It is possible to track multiple clinical studies, multiple patients per clinical trial and multiple events per patient. Events can be selected from the CTC-AE 4 and CTC-AE 5 databases, from Karnofsky and ECOG score tables or can be entered as customized events.
For convenience, all data can be exported as an excel CSV file to be imported into other analysis software.
########################
IMPORTANT NOTE
########################
This application is strictly EU GDPR compliant and no clinical study or patient information is saved outside the device or uploaded to any remote cloud resources.
In-Apps
- Adverse Event Logger
- $3.99
Screenshots
User Rating
3 out of 5
3 ratings in United States
5 star
1
4 star
0
3 star
1
2 star
0
1 star
1
Ratings History
Reviews
Great concept, but needs work
Sadly, poorly designed. Can’t save favorites and search terms are tedious. For example, can’t just search ALT- you have to spell it out. Great concept to have CTC-AE 4 and 5 in one app with performance scales, but please make it more user friendly! For an app that costs 2.99, should be bettter.
Search doesn’t work for titles
Edit 2019. Revising as promised due to developer response. Search “dyspnea”, nothing comes up. “Breath” and dyspnea will show as a search result. Same with fever and most of the AEs I search for. Make titles of the AE terms somehow searchable and I will revise to 5 stars. Until then I’m looking for a different app.
Needs more
The blood disorders section leaves out thrombocytopenia and leukopenia, for example.
Interesting app
An interesting and easy to use app. Perhaps adding in more adverse event definitions would be helpful, such as thrombocytopenia and leukopenia.
Add search tab 4 iPad!
Please add search capacity for iPad.
great!
so much better than carrying around the "not so little" notebook versions. any chance on getting ecog and karnofsky performance scals also?
Excellent program
As a clinical researcher, I find this program to be a great substitute for the usual spiral notebook!
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
45
|
|
Top Paid
|
|
46
|
|
Top Paid
|
|
86
|
|
Top Paid
|
|
90
|
|
Top Paid
|
|
95
|
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
OncoApp
|
0
|
6 years ago | |
Manual of Clinical Oncology
with Expert Recommentations
|
1
|
6 months ago | |
Cancer Pharmacology Manual
Anticancer Oncology Drug Guide
|
0
|
2 years ago | |
CTCAE v4.0
|
0
|
6 years ago | |
Cancer Guide: Prostate, Breast
|
2
|
6 years ago | |
TNM8 Breast Cancer Calculator
AJCC Licensed
|
3
|
6 years ago | |
CTCAE - Terminology 4.03
|
0
|
1 year ago | |
Therapy Protocols
and Targeted Therapies
|
1
|
1 year ago | |
CTCAE v4.0 (EN/JA) Edition
For all Medical personnel
|
0
|
2 years ago |
Show More
Revenue and Downloads
Gain valuable insights into CTC-AE+ performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Arpacore B.V.
- Languages
- English
- Recent version
- 3.1 (3 years ago )
- Released on
- Jan 7, 2010 (14 years ago )
- Also available in
- United States, Spain, Mexico, Netherlands, Germany, Portugal, Kuwait, Kazakhstan, Lebanon, Malaysia, Nigeria, Norway, New Zealand, Peru, Philippines, Poland, Japan, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, Vietnam, South Africa, Egypt, Argentina, Australia, Brazil, Canada, Switzerland, Chile, China, Colombia, Czechia, Denmark, Algeria, Ecuador, South Korea, Finland, France, United Kingdom, Greece, Hong Kong, Hungary, Ireland, Israel, India, Italy, United Arab Emirates
- Last updated
- 2 weeks ago